CXCL13 and systemic lupus erythematosus: Opposite the pronounced CXCL13 elevations (elevated six times relative to controls) encountered in active SLE 12 and active rheumatoid arthritis 36, the long clinical history with type I diabetes, characterizing our IDDM ESRD patients (data not shown), was consistent with extinguished insulitis 37.